expression in adenocarcinoma of the

esophagogastric junctio

Mediation effect of hope on the relationship between inner strength and self-management in patients after percutaneous coronary intervention

BackgroundEffective self-management can enhance a patient’s quality of life and delay disease progression. However, motivating patients to adhere to self-management behavior following percutaneous coronary intervention (PCI) remains a challenge. With the robust development of positive psychology and interdisciplinary research, the role of psychology factors in patients’ health behavior has increasingly garnered attention. This study, focusing on positive psychological qualities, aims to investigate the relationship between inner strength, hope, and self-management in patients post-PCI, and to analyze the mediating role of hope between inner strength and self-management.MethodsA cross-sectional survey was conducted among 216 PCI patients from a tertiary hospital in Nanjing. Research instruments included a self-designed general information questionnaire, the Inner Strength Scale (ISS), the Herth Hope Index (HHI), and the Coronary Self-Management Scale (CSMS). T-test, analysis of variance, Pearson’s correlation analysis, and mediating effect test were utilized for statistical analysis.ResultsThe average scores of the ISS, HHI, and CSMS were 81.46 ± 12.00, 35.94 ± 5.38, and 86.79 ± 14.84, respectively. Inner strength was positively correlated with hope and self-management (r = 0.867, r = 0.630, respectively; all P < 0.05), and hope was positively correlated with self-management (r = 0.671, P < 0.05). Moreover, hope had a complete mediating effect between inner strength and self-management (β = 0.630, P < 0.01).ConclusionThe inner strength, hope, and self-management of patients with PCI are at a moderate level. Inner strength primarily influences patients’ self-management behavior through hope, suggesting that medical staff can target hope to help patients build confidence in life after illness, form and accumulate inner strength, thereby promoting their self-management and improving prognosis

The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives

Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, is a chronic relapsing gastrointestinal inflammatory disease mediated by dysregulated immune responses to resident intestinal microbiota. Current conventional approaches including aminosalicylates, corticosteroids, immunosuppressive agents, and biological therapies are focused on reducing intestinal inflammation besides inducing and maintaining disease remission, and managing complications. However, these therapies are not curative and are associated with various limitations, such as drug resistance, low responsiveness and adverse events. Recent accumulated evidence has revealed the involvement of mucin-degrading bacterium Akkermansia muciniphila (A. muciniphila) in the regulation of host barrier function and immune response, and how reduced intestinal colonisation of probiotic A. muciniphila can contribute to the process and development of inflammatory bowel diseases, suggesting that it may be a potential target and promising strategy for the therapy of inflammatory bowel disease. In this review, we summarise the current knowledge of the role of A. muciniphila in IBD, especially focusing on the related mechanisms, as well as the strategies based on supplementation with A. muciniphila, probiotics and prebiotics, natural diets, drugs, and herbs to promote its colonisation in the gut, and holds promise for A. muciniphila-targeted and -based therapies in the treatment of inflammatory bowel disease

Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo

<p>Abstract</p> <p>Background</p> <p>Oncolytic virotherapy is an attractive drug platform of cancer gene therapy, but efficacy and specificity are important prerequisites for success of such strategies. Previous studies determined that Apoptin is a p53 independent, bcl-2 insensitive apoptotic protein with the ability to specifically induce apoptosis in tumor cells. Here, we generated a conditional replication-competent adenovirus (CRCA), designated Ad-hTERT-E1a-Apoptin, and investigated the effectiveness of the CRCA a gene therapy agent for further clinical trials.</p> <p>Results</p> <p>The observation that infection with Ad-hTERT-E1a-Apoptin significantly inhibited growth of the melanoma cells, protecting normal human epidermal melanocytes from growth inhibition confirmed cancer cell selective adenoviral replication, growth inhibition, and apoptosis induction of this therapeutic approach. The <it>in vivo </it>assays performed by using C57BL/6 mice containing established primary or metastatic tumors expanded the <it>in vitro </it>studies. When treated with Ad-hTERT-E1a-Apoptin, the subcutaneous primary tumor volume reduction was not only observed in intratumoral injection group but in systemic delivery mice. In the lung metastasis model, Ad-hTERT-E1a-Apoptin effectively suppressed pulmonary metastatic lesions. Furthermore, treatment of primary and metastatic models with Ad-hTERT-E1a-Apoptin increased mice survival.</p> <p>Conclusions</p> <p>These data further reinforce the previously research showing that an adenovirus expressing Apoptin is more effective and advocate the potential applications of Ad-hTERT-E1a-Apoptin in the treatment of neoplastic diseases in future clinical trials.</p

Simulation of Carbon Exchange from a Permafrost Peatland in the Great Hing’an Mountains Based on CoupModel

Climate change is accelerating its impact on northern ecosystems. Northern peatlands store a considerable amount of C, but their response to climate change remains highly uncertain. In order to explore the feedback of a peatland in the Great Hing’an Mountains to future climate change, we simulated the response of the overall net ecosystem exchange (NEE), ecosystem respiration (ER), and gross primary production (GPP) during 2020–2100 under three representative concentration pathways (RCP2.6, RCP6.0, and RCP8.5). Under the RCP2.6 and RCP6.0 scenarios, the carbon sink will increase slightly until 2100. Under the RCP8.5 scenario, the carbon sink will follow a trend of gradual decrease after 2053. These results show that when meteorological factors, especially temperature, reach a certain degree, the carbon source/sink of the peatland ecosystem will be converted. In general, although the peatland will remain a carbon sink until the end of the 21st century, carbon sinks will decrease under the influence of climate change. Our results indicate that in the case of future climate warming, with the growing seasons experiencing overall dryer and warmer environments and changes in vegetation communities, peatland NEE, ER, and GPP will increase and lead to the increase in ecosystem carbon accumulation

Digital Twin-Driven Tool Wear Monitoring and Predicting Method for the Turning Process

Accurate monitoring and prediction of tool wear conditions have an important influence on the cutting performance, thereby improving the machining precision of the workpiece and reducing the production cost. However, traditional methods cannot easily achieve exact supervision in real time because of the complexity and time-varying nature of the cutting process. A method based on Digital Twin (DT), which establish a symmetrical virtual tool system matching exactly the actual tool system, is presented herein to realize high precision in monitoring and predicting tool wear. Firstly, the framework of the cutting tool system DT is designed, and the components and operations rationale of the framework are detailed. Secondly, the key enabling technologies of the framework are elaborated. In terms of the cutting mechanism, a virtual cutting tool model is built to simulate the cutting process. The modifications and data fusion of the model are carried out to keep the symmetry between physical and virtual systems. Tool wear classification and prediction are presented based on the hybrid-driven method. With the technologies, the physical–virtual symmetry of the DT model is achieved to mapping the real-time status of tool wear accurately. Finally, a case study of the turning process is presented to verify the feasibility of the framework

Highly efficient microbial lipid synthesis from co-fermentation of enzymatic hydrolysate of sugarcane bagasse by a Trichosporon dermatis mutant

In this study, an oleaginous yeast Trichosporon dermatis was mutated by a sequential plasma and chemical mutagenesis approach. The best mutant (L7) was investigated to produce lipid from enzymatic hydrolysates derived from pretreated sugarcane bagasse at different scales and cultivation modes. The results showed that in shake flasks, L7 produced 26.7 g/L cell mass with 14.0 g/L lipid from the hydrolysate medium containing 80 g/L glucose/xylose (mass ratio of 2:1) in batch mode, and 34.9 g/L cell mass with 20.2 g/L lipid from the medium containing a total of 120 g/L glucose/xylose (2:1) in fed-batch mode, respectively. In a 5 L fermenter, L7 produced 33.3 g/L cell mass with 18.1 g/L lipid in batch mode and 51.5 g/L cell mass with 31.3 g/L lipid in fed-batch mode, respectively. This study demonstrates that L7 is highly efficient T. dermatis strain to produce lipid using glucose and xylose mixture derived from lignocellulose

Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant

Aim. This study aims to uncover the pharmacological mechanism of Tongxie Anchang Decoction (TXACD), a new and effective traditional Chinese medicine (TCM) prescription, for treating irritable bowel syndrome with diarrhea predominant (IBS-D) using network pharmacology. Methods. The active compounds and putative targets of TXACD were retrieved from TCMSP database and published literature; related target genes of IBS-D were retrieved from GeneCards; PPI network of the common target hub gene was constructed by STRING. Furthermore, these hub genes were analyzed using gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Results. A total of 54 active compounds and 639 targets were identified through a database search. The compound-target network was constructed, and the key compounds were screened out according to the degree. By using the PPI and GO and KEGG enrichment analyses, the pharmacological mechanism network of TXACD in the treatment of IBS-D was constructed. Conclusions. This study revealed the possible mechanisms by which TXACD treatment alleviated IBS-D involvement in the modulation of multiple targets and multiple pathways, including the immune regulation, inflammatory response, and oxidative stress. These findings provide novel insights into the regulatory role of TXACD in the prevention and treatment of IBS-D and hold promise for herb-based complementary and alternative therapy

Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction

Qingchang Wenzhong Decoction (QCWZD) is a newly developed, effective traditional Chinese herbal formulation for ulcerative colitis (UC). In earlier studies, we found that QCWZD could relieve the clinical symptoms of UC patients, reduce inflammation, and improve the intestinal barrier function in dextran sulphate sodium (DSS)-induced UC rats. However, the relationship between QCWZD and the gut microbiota in colitis was not clarified. In this study, we established a rat model of DSS-induced UC and then investigated the regulatory effects of QCWZD on the gut microbiota using 16S rRNA analysis. We also determined the expression of NLRP12 after QCWZD administration. Our findings suggested that QCWZD administration could modulate gut microbiota composition and selectively promote the protective strains such as Butyricimonas, Blautia, and Odoribacter, whereas the enteric pathogens including Clostridium and Dorea were significantly reduced after QCWZD treatment. It is noteworthy that QCWZD administration was identified to promote gut microbiota-mediated NLRP12 expression by inhibiting the activity of the TLR4/Blimp-1 axis. In conclusion, our study supports the potential of QCWZD administration as a beneficial therapeutic strategy for UC